Cabaser 2 mg, Tabletten
7680533620024
CH-53362
Tabletten
Associated product:
CABASER cpr 2 mg fl 20 pce
1 / 3
google
Article details
- Package size
- 20
- Selling units
- 20
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cabergolinum
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
leucinum
|
- | Substance | HNIDK |
|
lactosum
|
150.8 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 53362
- Drug name
- Cabaser, Tabletten
- Galenic form
- TAB
- ATC Code
- N04BC06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 23/01/1996
- Authorization expiration date
- 30/09/2026
- IT Number
- 01.08.0.
- Domain
- Human medicine
Package details
- Description (FR)
- CABASER cpr 2 mg fl 20 pce
- Description (DE)
- CABASER Tabl 2 mg Fl 20 Stk
- Market launch
- 23/01/1996
- Narcotic (BTM)
- No
Other package sizes (6)
CABASER cpr 1 mg fl 20 pce
20 TABL
GTIN: 7680533620017
None
None None
GTIN: None
None
None None
GTIN: None
CABASER cpr 2 mg 3 x 20 pce
None None
GTIN: 7680533620871
CABASER cpr 4 mg 16 pce
16 TABL
GTIN: 7680533620796
CABASER cpr 4 mg 3 x 16 pce
3 x 16 TABL
GTIN: 7680533620956